Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2507
https://www.valueinhealthjournal.com/article/S1098-3015(14)04437-4/fulltext
Title :
Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04437-4&doi=10.1016/j.jval.2014.08.2507
First page :
A675
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1958